This novel Δ2–4Merlin antibody (Merlin N15) solely targeted Δ2–4Merlin (Fig. 3g) and identified Δ2–4Merlin expression in HCC and PVTT tissues (Fig. 3h). Here, NF2 is linked to hepatocellular carcinoma.